The smart move is to ignore the gendered marketing and buy a plain, third-party-tested creatine monohydrate powder, which is what the ISSN position stand has recommended for years
Functional medicine practitioners are already exploring its use in recovery protocols, with patient experiences reinforcing its potential
Notably: BPC-157, KPV, MOTs-C, Emideltide (DSIP), Epitalon, Semax (heptapeptide) and TB-500 are among those expected to be reviewed in July 2026 Other substances, including Cathelicidin LL-37, Dihexa Acetate, PEG-MGF, GHK-Cu and Melanotan II, are under consideration for review by early 2027 Non-injectable GHK-Cu is following a slightly different path, with separate evaluation anticipated before February 2027
KEY OBSERVATIONS Cancellation was one quick, easy button in the patient portal
Skinner, S
Prescriptions from other types of practitioners are not valid for these medicines